BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 28804051)

  • 1. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.
    Morris MD; Neilands TB; Andrew E; Maher L; Page KA; Hahn JA
    Int J Drug Policy; 2017 Oct; 48():54-62. PubMed ID: 28804051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.
    Morris MD; Andrew E; Tan JY; Maher L; Hoff C; Darbes L; Page K
    PLoS One; 2019; 14(5):e0217811. PubMed ID: 31150518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.
    Evans JL; Morris MD; Yu M; Page K; Hahn JA
    Drug Alcohol Depend; 2014 Sep; 142():239-44. PubMed ID: 25034898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More than just someone to inject drugs with: Injecting within primary injection partnerships.
    Morris MD; Bates A; Andrew E; Hahn J; Page K; Maher L
    Drug Alcohol Depend; 2015 Nov; 156():275-281. PubMed ID: 26460140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.
    Morris MD; Evans J; Montgomery M; Yu M; Briceno A; Page K; Hahn JA
    PLoS One; 2014; 9(10):e109282. PubMed ID: 25286346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
    Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
    Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
    Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
    Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
    Spelman T; Morris MD; Zang G; Rice T; Page K; Maher L; Lloyd A; Grebely J; Dore GJ; Kim AY; Shoukry NH; Hellard M; Bruneau J;
    J Epidemiol Community Health; 2015 Aug; 69(8):745-52. PubMed ID: 25814695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners.
    Morris MD; Montgomery ME; Briceno A; Evans JL; Andrew EVW; Page K; Hahn JA
    Subst Use Misuse; 2018 Jul; 53(8):1281-1287. PubMed ID: 29286888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine.
    Mazhnaya A; Tobin KE; Owczarzak J
    Drug Alcohol Depend; 2018 Aug; 189():125-130. PubMed ID: 29913323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).
    Evans JL; Hahn JA; Page-Shafer K; Lum PJ; Stein ES; Davidson PJ; Moss AR
    J Urban Health; 2003 Mar; 80(1):137-46. PubMed ID: 12612103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting.
    Bryant J; Brener L; Hull P; Treloar C
    Drug Alcohol Depend; 2010 Mar; 107(2-3):182-7. PubMed ID: 19942380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
    Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
    AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.